Susquehanna International Securities’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-148,200
Closed -$5.18M 29
2020
Q4
$5.18M Hold
148,200
3.76% 11
2020
Q3
$5.14M Hold
148,200
2.71% 13
2020
Q2
$4.85M Hold
148,200
2.01% 14
2020
Q1
$4.46M Sell
148,200
-2,000
-1% -$59.5K 1.81% 16
2019
Q4
$4.35M Buy
150,200
+1,200
+0.8% +$33.2K 1.65% 18
2019
Q3
$3.85M Buy
149,000
+42,200
+40% +$1.07M 0.84% 37
2019
Q2
$2.73M Buy
+106,800
New +$2.64M 0.88% 30

Other funds holding NVO

Susquehanna International Securities's NVO Position: Q1 2024 in Review

Susquehanna International Securities sold out of Novo Nordisk (NVO) in Q1 2024, closing a stake of 3,456 shares — an estimated $358K sold.

Susquehanna International Securities first reported a position in NVO in Q1 2019 and held it in 7 quarters. The position peaked at $4.65M in Q3 2019. 1,745 funds tracked by Wall St. Rank hold NVO as of Q1 2024.

  • Susquehanna International Securities reported no remaining Novo Nordisk position as of Q1 2024 after selling out during the quarter.
  • Susquehanna International Securities sold 3,456 Novo Nordisk shares in Q1 2024, an estimated $358K.
  • Susquehanna International Securities first reported a position in Novo Nordisk in Q1 2019 and held it in 7 quarters.
  • Susquehanna International Securities's Novo Nordisk position peaked at $4.65M in Q3 2019.
  • 1,745 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2024.

Based on Susquehanna International Securities's 13F filing for Q1 2024, filed 7 May 2024.